In a presentation at the 227th National Meeting of the American Chemical Society, Illinois doctoral student Wenjuan Zha reported how the fatty acid biosynthetic pathway of Brevibacterium ammoniagenes, a bacterium commonly found in the human intestinal tract, was used for the first time with glucose -- rather than petroleum or other chemicals from non-renewable resources -- to produce triacetic acid lactone (TAL).
In a study published on line late last month, ahead of regular print publication in the Journal of the American Chemical Society, Zha and colleagues detailed their proposed biochemical mechanism, which allows the fatty acid synthase pathway (FAS-B) to use glucose to make TAL. TAL is an energetic precursor for TATB, an explosive much more stable and sensitive than TNT.
Subsequently, Zha said, TAL can be chemically changed to phloroglucinol, a pivotal structure necessary for the synthesis of a variety of bioactive and energetic compounds.
FAS-B is a primary metabolic enzyme with multiple functions, and it may be used to make many diverse value-added compounds, said Zha's adviser Huimin Zhao, a professor of chemical and biomolecular engineering and of chemistry at Illinois.
To accomplish their task, the researchers had to understand the various domains of FAS-B that are necessary for fatty acid synthesis. Zha described how she and her colleagues used a variety of bioinformatics tools, such as the Web-accessible Biology Workbench, to analyze the gene sequence of FAS-B and identify the key catalytic residues.
They discovered that if they disabled the ketoacyl-reductase domain by replacing
'"/>
Contact: Jim Barlow, Life Sciences Editor
jebarlow@staff.uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign
1-Apr-2004